Tender

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NP39726 Generic and Biosimilar Cancer Medicines

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

This public procurement record has 2 releases in its history.

TenderUpdate

30 Jul 2026 at 01:00

OJEU - F14 - Corrigendum
Tender

24 Jul 2026 at 01:00

OJEU - F2 - Contract Notice
Summary of the contracting process

Public Services Delivery Scotland, on behalf of NHS Scotland, is procuring generic and biosimilar cancer medicines for use by NHS Scotland bodies and Integrated Joint Boards across Scotland. The requirement covers a broad range of medicines, including tablets, capsules, injectable and infusion medicines, pre-filled syringes, ampoules and medicine lines. Products include bendamustine, capecitabine, carboplatin, docetaxel, fluorouracil, gemcitabine, paclitaxel, pemetrexed, lenalidomide, pomalidomide, thalidomide and others. The procurement is for goods, classified under CPV 33600000. It is divided into 36 product or product-group lots, including individual medicines and broader ranges of cancer medicine lines. Suppliers may bid for any number of lots, making this relevant to manufacturers, marketing authorisation holders, wholesalers and specialist pharmaceutical distributors able to supply NHS Scotland at scale.

The procurement has reached tender: the buyer invited offers through an open procedure, with electronic submission. The tender deadline, as amended, is 1 September 2026 at 12:00, with tender opening at the same time. The framework is intended to run from 1 February 2027 to 31 January 2029, except the Lenvatinib lot, which starts on 1 May 2027; each framework may be extended by up to 24 months. The estimated value is £197,026,942, covering the initial and extension periods. Lot values range from £14,436 for Pemetrexed powder to £45,208,332 for ranked cancer medicine lines. Most lots are single-supplier frameworks; others allow up to three suppliers, or up to six for one lot. Evaluation is mainly price and logistics: generally 95% price and 5% logistics, with some lots weighted 90% price and 5% logistics.

This opportunity suits pharmaceutical manufacturers, authorised distributors, wholesalers and specialist NHS medicines suppliers with reliable UK supply chains and experience delivering regulated cancer medicines. Bidders must hold a valid, current UK Marketing Authorisation approved by the MHRA for every medicine tendered by the framework start date. The bidder and any subcontractors must hold BS EN ISO 9001 certification or an equivalent standard. Products must meet MHRA best-practice guidance and National Patient Safety Agency guidelines for packaging and labelling, with samples supplied when requested. Suppliers need the capacity to support national NHS Scotland distribution, demonstrate robust logistics and manage single-supplier or ranked multi-supplier framework commitments. They must also provide a climate change plan, support community benefits, and accept electronic ordering and payment arrangements.

How relevant is this notice?

Notice Information

Notice Title

NP39726 Generic and Biosimilar Cancer Medicines

Notice Description

Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.

Lot Information

Bendamustine powder for solution for infusion vials

Supply of Lot 1 Bendamustine powder for solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Capecitabine tablets

Supply of Capecitabine tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cisplatin solution for infusion vials

Supply of Cisplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cyclophosphamide powder for solution for injection vials

Supply of Cyclophosphamide powder for solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cytarabine solution for injection vials

Supply of Cytarabine solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Dacarbazine powder for solution for injection/infusion vials

Supply of Dacarbazine powder for solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Disodium folinate solution for injection vials

Supply of Disodium folinate solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Docetaxel solution for infusion vials

Supply of Docetaxel solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Fluorouracil 25mg/ml solution for injection/infusion vials

Supply of Fluorouracil 25mg/ml solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Fluorouracil 50mg/ml solution for injection/infusion vials

Supply of Fluorouracil 50mg/ml solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Gemcitabine 38mg/ml solution for infusion vials

Supply of Gemcitabine 38mg/ml solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Gemcitabine 100mg/ml solution for infusion vials

Supply of Gemcitabine 100mg/ml solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Ifosfamide powder for solution for injection vials

Supply of Ifosfamide powder for solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate solution for injection/infusion vials

Supply of Methotrexate solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Oxaliplatin solution for infusion vials

Supply of Oxaliplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Paclitaxel solution for infusion vials

Supply of Paclitaxel solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Temozolomide capsules

Supply of Temozolomide capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Vincristine solution for injection vials

Supply of Vincristine solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Vinorelbine solution for infusion vials

Supply of Vinorelbine solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Aprepitant capsules

Supply of Aprepitant capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Octreotide solution for injection ampoules

Supply of Octreotide solution for injection ampoules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Filgrastim solution for injection pre-filled syringes

Supply of Filgrastim solution for injection pre-filled syringes to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Pemetrexed powder for solution for infusion vials

Supply of Pemetrexed powder for solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Pemetrexed solution for infusion vials

Supply of Pemetrexed solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Dasatinib tablets

Supply of Dasatinib tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Azacitidine, bevacizumab, doxorubicin pegylated liposomal, lanreotide, octreotide, rituximab and trastuzumab lines

Supply of Azacitidine, bevacizumab, doxorubicin pegylated liposomal, lanreotide, octreotide, rituximab and trastuzumab lines to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework agreement to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lenalidomide capsules

Supply of Lenalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Pomalidomide capsules

Supply of Pomalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire

Thalidomide capsules

Supply of Thalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Irinotecan solution for infusion vials

Supply of Irinotecan solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Etoposide solution for infusion vials

Supply of Etoposide solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Doxorubicin solution for injection vials

Supply of Doxorubicin solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Carboplatin solution for infusion vials

Supply of Carboplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lenvatinib capsules

Supply of Lenvatinib capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Range of ranked cancer medicine lines

Supply of a range of ranked cancer medicine lines to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Range of single-supplier cancer medicine lines

Supply of a range of single-supplier cancer medicine lines to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per product line. Full details of Goods and volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000838357
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL561277
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
OJEU - F14 - Corrigendum
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£197,026,942 £100M-£1B
Lots Value
£152,264,804 £100M-£1B
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
30 Jul 20262 months ago
Submission Deadline
26 Aug 2026Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...